Clinical Study

Randomized Phase II Trial Of Hypofractionated Dose-Escalated Photon Imrt Or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant And Adjuvant Temozolomide In Patients With Newly Diagnosed Glioblastoma

Posted Date: Feb 16, 2017

  • Investigator: Kevin Redmond
  • Co-Investigator: Rachel Podell
  • Specialties: Hematology/Oncology, Oncology, Cancer
  • Type of Study: Drug

The purpose of this study is to compare a different radiation therapy schedule and higher radiation dose to the standard dose of radiation therapy. All patients will receive usual chemotherapy, temozolomide. This study will allow researchers to know wheth


To Be Eligible For This Study, Patients Must Have A Brain Tumor Called Glioblastoma.


Tumor, Brain , Cancer, Glioblastoma, Nrg-Bn001

For More Information:

Uc Cancer Institute

  • Search Clinical Studies

  • Research in the News

    Ride Cincinnati Gives $200,000 in Grants for Breast Cancer Research

    Marlene Harris-Ride Cincinnati has continued its support of UC Cancer Institutescientists with the annual award of five grants to continue promising breastcancer research.